tirzepatide injection vial Lilly releases Zepbound® (tirzepatide) single-dose

Unlike previous treatments that target only one hormone receptor, this medicine is a "dual agonist," meaning it activates both GIP and GLP-1 receptors

For physicians practicing functional and anti-aging medicine, the critical metric is the improvement in underlying cardiovascular and metabolic markers

TB-500 stimulates VEGF expression and endothelial migration, BPC-157 stabilizes capillary walls, GHK-Cu promotes angiogenesis, and KPV enhances mitochondrial oxygen utilization

Enhanced Metabolic Profiles : Patients frequently witness improvements in vital metabolic indicators such as blood sugar levels, blood pressure, and cholesterol, not to mention a decline in inflammation markers

doi:10.1016/j.mrgentox.2006.05.006

Enhanced Fat-Burning: Both help target excess fat while preserving lean muscle